Sciele Pharma, Inc., headquartered in Atlanta Georgia is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and Attention Deficit/Hyperactivity Disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity, and Teamwork. For more information, visit: www.sciele.com.

Contact Information

Five Concourse Parkway
Suite 1800
Atlanta, GA 30328

tel: 770-442-9707
fax: 770-442-9594


Investor Relations



Exchange: NASDAQ
Industry: Drug Manufacturers - Other
Market Cap: $752.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.